Literature DB >> 22194515

Added value of percutaneous vertebroplasty: effects on respiratory function.

Noboru Tanigawa1, Shuji Kariya, Atsushi Komemushi, Miyuki Nakatani, Rie Yagi, Satoshi Sawada.   

Abstract

OBJECTIVE: The objective of our study was to investigate the effects of percutaneous vertebroplasty on respiratory function in patients with compression fractures caused by osteoporosis. SUBJECTS AND METHODS: Ninety-eight patients (87 women, 11 men; mean age, 74 years; age range, 60-90 years) with compression fractures of 75 thoracic (Th7-Th12) and 89 lumbar (L1-L5) vertebrae were enrolled in this study. Percentage vital capacity (VC%), percentage forced vital capacity (FVC%), and percentage forced expiratory volume in 1 second (%FEV1) were measured using a spirometer before, 1 day after, and 1 month after percutaneous vertebroplasty. The Wilcoxon signed rank test was used to evaluate whether any significant differences in VC%, FVC%, or %FEV1 values existed between before, 1 day after, and 1 month after percutaneous vertebroplasty.
RESULTS: The VC% and FVC% values had improved significantly by 1 month after percutaneous vertebroplasty compared with before percutaneous vertebroplasty (p<0.01). No significant difference was noted between values before and 1 day after percutaneous vertebroplasty. Likewise, no significant difference was identified in %FEV1 before percutaneous vertebroplasty and either 1 day or 1 month after percutaneous vertebroplasty. The mean degree of improvement in VC% values after percutaneous vertebroplasty for patients with one vertebra treated, which we refer to as the "single-vertebroplasty" group, and for patients with two or more vertebrae treated, or "multiple-vertebroplasty" group, was 1.1%±7% (SD) and 6.3%±8%, respectively, representing a significant difference between groups (p=0.01). The mean VC% values before and 1 month after percutaneous vertebroplasty differed significantly (p=0.02) in the thoracic group and overlapping group.
CONCLUSION: Percutaneous vertebroplasty improves restrictive ventilatory impairment, but this improvement requires approximately 1 month to occur. Greater improvement in restrictive ventilatory dysfunction was observed in patients who underwent multiple vertebroplasty procedures than those who underwent a single procedure and in patients who underwent treatment of thoracic vertebrae than those who underwent treatment of other vertebrae.

Entities:  

Mesh:

Year:  2012        PMID: 22194515     DOI: 10.2214/AJR.11.6730

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  5 in total

1.  Improvement in Pulmonary Function of Chronic Obstructive Pulmonary Disease (COPD) Patients With Osteoporotic Vertebral Compression Fractures (OVCFs) After Kyphoplasty Under Local Anesthesia.

Authors:  Song Sheng; Sun Zhenzhong; Jiang Weimin; Wang Yimeng; Yin Qudong; Shi Jinhui
Journal:  Int Surg       Date:  2015-03

Review 2.  Public health impact of osteoporosis.

Authors:  Jane A Cauley
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-07-31       Impact factor: 6.053

3.  Restrictive pulmonary dysfunction is associated with vertebral fractures and bone loss in elderly postmenopausal women.

Authors:  R Watanabe; M Shiraki; M Saito; R Okazaki; D Inoue
Journal:  Osteoporos Int       Date:  2017-12-07       Impact factor: 4.507

4.  Chronic obstructive pulmonary disease (COPD) patients with osteoporotic vertebral compression fractures (OVCFs): improvement of pulmonary function after percutaneous vertebroplasty (VTP).

Authors:  Salvatore Masala; Andrea Magrini; Amedeo Taglieri; Giovanni Nano; Antonio Chiaravalloti; Eros Calabria; Roberta Di Trapano; Antonio Pietroiusti; Giovanni Simonetti
Journal:  Eur Radiol       Date:  2014-04-18       Impact factor: 5.315

5.  Chronic obstructive pulmonary disease combined with vertebral compression fracture increases the risk of temporomandibular disorder: A population-based cohort study.

Authors:  Kuei-Chen Lee; Yung-Tsan Wu; Liang-Cheng Chen; Chih-Hao Shen; Chi-Hsiang Chung; Wu-Chien Chien; Yi-Shing Shieh
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.